Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €7.25 | - | - |
| NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.68 | - | - |
| Trevena Inc. | 2 | 19 | 0 | 1 | €0.18 | €6.48 | 3541.573% |
| Sage Therapeutics Inc. | 8 | 4 | 1 | 0 | €9.57 | €25.88 | 170.460% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.82 | €5.51 | 573.333% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.82 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €1.16 | €6.49 | 459.577% |
| Carl Zeiss Meditec AG | 2 | 1 | 0 | 0 | €60.95 | €122.00 | 100.164% |
| Evotec SE | 4 | 3 | 2 | 2 | €8.78 | €10.00 | 13.895% |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| Medtronic plc | 7 | 2 | 0 | 0 | €72.46 | €91.57 | 26.367% |
| T2 Biosystems Inc. | 0 | 7 | 0 | 0 | €0.16 | - | - |
| Immuron | 0 | 1 | 0 | 0 | €2.12 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.26 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.14 | - | - |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €1.07 | €2.00 | 87.617% |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €1.04 | - | - |
| Ryman Healthcare Group Ltd. | 1 | 1 | 0 | 0 | €2.41 | - | - |
| Avinger Inc. | 2 | 4 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Bristol-Myers Squibb | 9 | 2 | 0 | 0 | €44.38 | €70.67 | 59.245% |
| InVivo Therapeutics Holdings | 0 | 15 | 0 | 0 | €0.31 | - | - |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Uniqure B.V. | 1 | 2 | 1 | 2 | €7.86 | €11.00 | 40.020% |
| Nevro Corp. | 3 | 3 | 0 | 1 | €9.10 | €21.13 | 132.249% |
| Teladoc Health Inc | 12 | 1 | 0 | 0 | €8.64 | €23.12 | 167.626% |